 | • レポートコード：GIR-105X14519 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、リルピビリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。リルピビリンの種類別市場規模（自己製造API、アウトソーシングAPI）、用途別市場規模（病院、診療所、薬局、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・リルピビリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Janssen Cilag International、Gilead Sciences 、ViiV Healthcare、Strides Pharma Science Limited、Pharmacare Limited、Aspen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：自己製造API、アウトソーシングAPI ・用途別分析2016年-2026年：病院、診療所、薬局、その他 ・リルピビリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・リルピビリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・リルピビリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・リルピビリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・リルピビリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rilpivirine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rilpivirine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Rilpivirine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rilpivirine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Self-production API
Outsourcing of API
Market segment by Application can be divided into
Hospital
Clinic
Drug Center
Other
The key market players for global Rilpivirine market are listed below:
Janssen Cilag International
Gilead Sciences
ViiV Healthcare
Strides Pharma Science Limited
Pharmacare Limited
Aspen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Rilpivirine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rilpivirine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Self-production API
1.2.3 Outsourcing of API
1.3 Market Analysis by Application
1.3.1 Overview: Global Rilpivirine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Rilpivirine Market Size & Forecast
1.4.1 Global Rilpivirine Sales in Value (2016-2026))
1.4.2 Global Rilpivirine Sales in Volume (2016-2026)
1.4.3 Global Rilpivirine Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Rilpivirine Production Capacity Analysis
1.5.1 Global Rilpivirine Total Production Capacity (2016-2026)
1.5.2 Global Rilpivirine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rilpivirine Market Drivers
1.6.2 Rilpivirine Market Restraints
1.6.3 Rilpivirine Trends Analysis
2 Manufacturers Profiles
2.1 Janssen Cilag International
2.1.1 Janssen Cilag International Details
2.1.2 Janssen Cilag International Major Business
2.1.3 Janssen Cilag International Rilpivirine Product and Services
2.1.4 Janssen Cilag International Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences Rilpivirine Product and Services
2.2.4 Gilead Sciences Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 ViiV Healthcare
2.3.1 ViiV Healthcare Details
2.3.2 ViiV Healthcare Major Business
2.3.3 ViiV Healthcare Rilpivirine Product and Services
2.3.4 ViiV Healthcare Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Strides Pharma Science Limited
2.4.1 Strides Pharma Science Limited Details
2.4.2 Strides Pharma Science Limited Major Business
2.4.3 Strides Pharma Science Limited Rilpivirine Product and Services
2.4.4 Strides Pharma Science Limited Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pharmacare Limited
2.5.1 Pharmacare Limited Details
2.5.2 Pharmacare Limited Major Business
2.5.3 Pharmacare Limited Rilpivirine Product and Services
2.5.4 Pharmacare Limited Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Aspen
2.6.1 Aspen Details
2.6.2 Aspen Major Business
2.6.3 Aspen Rilpivirine Product and Services
2.6.4 Aspen Rilpivirine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Rilpivirine Sales by Manufacturer
3.1 Global Rilpivirine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Rilpivirine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Rilpivirine
3.4 Market Concentration Rate
3.4.1 Top 3 Rilpivirine Manufacturer Market Share
3.4.2 Top 6 Rilpivirine Manufacturer Market Share
3.5 Global Rilpivirine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Rilpivirine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rilpivirine Market Size by Region
4.1.1 Global Rilpivirine Sales in Volume by Region (2016-2026)
4.1.2 Global Rilpivirine Revenue by Region (2016-2026)
4.2 North America Rilpivirine Revenue (2016-2026)
4.3 Europe Rilpivirine Revenue (2016-2026)
4.4 Asia-Pacific Rilpivirine Revenue (2016-2026)
4.5 South America Rilpivirine Revenue (2016-2026)
4.6 Middle East and Africa Rilpivirine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Rilpivirine Sales in Volume by Type (2016-2026)
5.2 Global Rilpivirine Revenue by Type (2016-2026)
5.3 Global Rilpivirine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Rilpivirine Sales in Volume by Application (2016-2026)
6.2 Global Rilpivirine Revenue by Application (2016-2026)
6.3 Global Rilpivirine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Rilpivirine Sales by Type (2016-2026)
7.2 North America Rilpivirine Sales by Application (2016-2026)
7.3 North America Rilpivirine Market Size by Country
7.3.1 North America Rilpivirine Sales in Volume by Country (2016-2026)
7.3.2 North America Rilpivirine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Rilpivirine Sales by Type (2016-2026)
8.2 Europe Rilpivirine Sales by Application (2016-2026)
8.3 Europe Rilpivirine Market Size by Country
8.3.1 Europe Rilpivirine Sales in Volume by Country (2016-2026)
8.3.2 Europe Rilpivirine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Rilpivirine Sales by Type (2016-2026)
9.2 Asia-Pacific Rilpivirine Sales by Application (2016-2026)
9.3 Asia-Pacific Rilpivirine Market Size by Region
9.3.1 Asia-Pacific Rilpivirine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Rilpivirine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Rilpivirine Sales by Type (2016-2026)
10.2 South America Rilpivirine Sales by Application (2016-2026)
10.3 South America Rilpivirine Market Size by Country
10.3.1 South America Rilpivirine Sales in Volume by Country (2016-2026)
10.3.2 South America Rilpivirine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rilpivirine Sales by Type (2016-2026)
11.2 Middle East & Africa Rilpivirine Sales by Application (2016-2026)
11.3 Middle East & Africa Rilpivirine Market Size by Country
11.3.1 Middle East & Africa Rilpivirine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Rilpivirine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Rilpivirine Typical Distributors
12.3 Rilpivirine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Rilpivirine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Rilpivirine Revenue by Application, (USD Million), 2021-2026
Table 3. Janssen Cilag International Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Cilag International Major Business
Table 5. Janssen Cilag International Rilpivirine Product and Services
Table 6. Janssen Cilag International Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 8. Gilead Sciences Major Business
Table 9. Gilead Sciences Rilpivirine Product and Services
Table 10. Gilead Sciences Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. ViiV Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. ViiV Healthcare Major Business
Table 13. ViiV Healthcare Rilpivirine Product and Services
Table 14. ViiV Healthcare Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Strides Pharma Science Limited Basic Information, Manufacturing Base and Competitors
Table 16. Strides Pharma Science Limited Major Business
Table 17. Strides Pharma Science Limited Rilpivirine Product and Services
Table 18. Strides Pharma Science Limited Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pharmacare Limited Basic Information, Manufacturing Base and Competitors
Table 20. Pharmacare Limited Major Business
Table 21. Pharmacare Limited Rilpivirine Product and Services
Table 22. Pharmacare Limited Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Aspen Basic Information, Manufacturing Base and Competitors
Table 24. Aspen Major Business
Table 25. Aspen Rilpivirine Product and Services
Table 26. Aspen Rilpivirine Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Global Rilpivirine Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 28. Global Rilpivirine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 29. Market Position of Manufacturers in Rilpivirine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 30. Global Rilpivirine Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 31. Head Office and Rilpivirine Production Site of Key Manufacturer
Table 32. Global Rilpivirine Sales by Region (2016-2021e) & (K Pcs)
Table 33. Global Rilpivirine Sales by Region (2021-2026) & (K Pcs)
Table 34. Global Rilpivirine Revenue by Region (2016-2021e) & (USD Million)
Table 35. Global Rilpivirine Revenue by Region (2021-2026) & (USD Million)
Table 36. Global Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 37. Global Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 38. Global Rilpivirine Revenue by Type (2016-2021e) & (USD Million)
Table 39. Global Rilpivirine Revenue by Type (2021-2026) & (USD Million)
Table 40. Global Rilpivirine Price by Type (2016-2021e) & (USD/Pcs)
Table 41. Global Rilpivirine Price by Type (2021-2026) & (USD/Pcs)
Table 42. Global Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 43. Global Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 44. Global Rilpivirine Revenue by Application (2016-2021e) & (USD Million)
Table 45. Global Rilpivirine Revenue by Application (2021-2026) & (USD Million)
Table 46. Global Rilpivirine Price by Application (2016-2021e) & (USD/Pcs)
Table 47. Global Rilpivirine Price by Application (2021-2026) & (USD/Pcs)
Table 48. North America Rilpivirine Sales by Country (2016-2021e) & (K Pcs)
Table 49. North America Rilpivirine Sales by Country (2021-2026) & (K Pcs)
Table 50. North America Rilpivirine Revenue by Country (2016-2021e) & (USD Million)
Table 51. North America Rilpivirine Revenue by Country (2021-2026) & (USD Million)
Table 52. North America Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 53. North America Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 54. North America Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 55. North America Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 56. Europe Rilpivirine Sales by Country (2016-2021e) & (K Pcs)
Table 57. Europe Rilpivirine Sales by Country (2021-2026) & (K Pcs)
Table 58. Europe Rilpivirine Revenue by Country (2016-2021e) & (USD Million)
Table 59. Europe Rilpivirine Revenue by Country (2021-2026) & (USD Million)
Table 60. Europe Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 61. Europe Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 62. Europe Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 63. Europe Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 64. Asia-Pacific Rilpivirine Sales by Region (2016-2021e) & (K Pcs)
Table 65. Asia-Pacific Rilpivirine Sales by Region (2021-2026) & (K Pcs)
Table 66. Asia-Pacific Rilpivirine Revenue by Region (2016-2021e) & (USD Million)
Table 67. Asia-Pacific Rilpivirine Revenue by Region (2021-2026) & (USD Million)
Table 68. Asia-Pacific Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 69. Asia-Pacific Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 70. Asia-Pacific Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 71. Asia-Pacific Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 72. South America Rilpivirine Sales by Country (2016-2021e) & (K Pcs)
Table 73. South America Rilpivirine Sales by Country (2021-2026) & (K Pcs)
Table 74. South America Rilpivirine Revenue by Country (2016-2021e) & (USD Million)
Table 75. South America Rilpivirine Revenue by Country (2021-2026) & (USD Million)
Table 76. South America Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 77. South America Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 78. South America Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 79. South America Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 80. Middle East & Africa Rilpivirine Sales by Country (2016-2021e) & (K Pcs)
Table 81. Middle East & Africa Rilpivirine Sales by Country (2021-2026) & (K Pcs)
Table 82. Middle East & Africa Rilpivirine Revenue by Country (2016-2021e) & (USD Million)
Table 83. Middle East & Africa Rilpivirine Revenue by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Rilpivirine Sales by Type (2016-2021e) & (K Pcs)
Table 85. Middle East & Africa Rilpivirine Sales by Type (2021-2026) & (K Pcs)
Table 86. Middle East & Africa Rilpivirine Sales by Application (2016-2021e) & (K Pcs)
Table 87. Middle East & Africa Rilpivirine Sales by Application (2021-2026) & (K Pcs)
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Rilpivirine Typical Distributors
Table 91. Rilpivirine Typical Customers
List of Figures
Figure 1. Rilpivirine Picture
Figure 2. Global Rilpivirine Sales Market Share by Type in 2020
Figure 3. Self-production API
Figure 4. Outsourcing of API
Figure 5. Global Rilpivirine Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Drug Center
Figure 9. Other
Figure 10. Global Rilpivirine Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Rilpivirine Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Rilpivirine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Rilpivirine Sales (2016-2026) & (K Pcs)
Figure 32. Global Rilpivirine Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Rilpivirine Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Rilpivirine Market Drivers
Figure 35. Rilpivirine Market Restraints
Figure 36. Rilpivirine Market Trends
Figure 37. Global Rilpivirine Sales Market Share by Manufacturer in 2020
Figure 38. Global Rilpivirine Revenue Market Share by Manufacturer in 2020
Figure 39. Rilpivirine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Rilpivirine Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Rilpivirine Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Rilpivirine Sales Market Share by Region (2016-2026)
Figure 43. Global Rilpivirine Revenue Market Share by Region (2016-2026)
Figure 44. North America Rilpivirine Revenue (2016-2026) & (USD Million)
Figure 45. Europe Rilpivirine Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Rilpivirine Revenue (2016-2026) & (USD Million)
Figure 47. South America Rilpivirine Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Rilpivirine Revenue (2016-2026) & (USD Million)
Figure 49. Global Rilpivirine Sales Market Share by Type (2016-2026)
Figure 50. Global Rilpivirine Revenue Market Share by Type (2016-2026)
Figure 51. Global Rilpivirine Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Rilpivirine Sales Market Share by Application (2016-2026)
Figure 53. Global Rilpivirine Revenue Market Share by Application (2016-2026)
Figure 54. Global Rilpivirine Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Rilpivirine Sales Market Share by Country (2016-2026)
Figure 56. North America Rilpivirine Revenue Market Share by Country (2016-2026)
Figure 57. North America Rilpivirine Sales Market Share by Type (2016-2026)
Figure 58. North America Rilpivirine Sales Market Share by Application (2016-2026)
Figure 59. Europe Rilpivirine Sales Market Share by Country (2016-2026)
Figure 60. Europe Rilpivirine Revenue Market Share by Country (2016-2026)
Figure 61. Europe Rilpivirine Sales Market Share by Type (2016-2026)
Figure 62. Europe Rilpivirine Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Rilpivirine Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Rilpivirine Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Rilpivirine Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Rilpivirine Sales Market Share by Application (2016-2026)
Figure 67. South America Rilpivirine Sales Market Share by Country (2016-2026)
Figure 68. South America Rilpivirine Revenue Market Share by Country (2016-2026)
Figure 69. South America Rilpivirine Sales Market Share by Type (2016-2026)
Figure 70. South America Rilpivirine Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Rilpivirine Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Rilpivirine Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Rilpivirine Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Rilpivirine Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のドルテグラビル/リルピビリン併用薬市場 2021：企業別、地域別、種類・用途別 The Dolutegravir/Rilpivirine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 世界のエムトリシタビン/リルピビリン/テノホビルアラフェナミド市場 2021：企業別、地域別、種類・用途別 The Emtricitabine/Rilpivirine/Tenofovir Alafenamide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 創薬外部委託の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big pharmaceuticals, patent expiration, shift towards biologics have seen a surge in the externalization and outsourcing activities. As the industry is looking …
- 医薬品の充填と仕上げの外注の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Pharmaceuticals contract manufacturing products are biotechnological products, which include drugs, lotions, and ointments. These products are outsourced to third parties to achieve their fill-and-finish requirements. Scope of the Report: This report studies the Pharmaceutical Fill and Finish Outsou…
- 世界のテノホビル/エムトリシタビン併用薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir/Emtricitabine Combination Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…